Press Releases

Date	Title	PDF Version
Jun 14, 2010	Substantial Disease Burden of PNH Demonstrated in Data from International and Asian Patient Registries Presented at European Hematology Association
Jun 02, 2010	Alexion to Present at Investor Conferences
Jun 02, 2010	Alexion Accelerates Plans to Launch Soliris(R) (Eculizumab) in Japan
Jun 01, 2010	Alexion Announces the Appointment of Ann M. Veneman to Its Board of Directors
May 19, 2010	Alexion to Present at the Citi 2010 Global Health Care Conference
May 06, 2010	Alexion to Present at the Bank of America Merrill Lynch 2010 Healthcare Conference
Apr 30, 2010	Research to be Presented at the American Transplant Congress Examines the Role of Terminal Complement Inhibition in the Treatment of Kidney Transplantation Patients
Apr 22, 2010	Alexion Reports First Quarter 2010 Results
Apr 20, 2010	Alexion Completes Enrollment in All Four Clinical Trials of Soliris(R) (eculizumab) in Patients with Atypical Hemolytic Uremic Syndrome (aHUS)
Apr 16, 2010	Alexion's Soliris(R) (Eculizumab) Receives Marketing Approval in Japan for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Search